Moran Wealth Management LLC Buys New Shares in ALPS Medical Breakthroughs ETF $SBIO

Moran Wealth Management LLC bought a new stake in ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 9,981 shares of the company’s stock, valued at approximately $300,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Strategic Financial Services Inc. boosted its stake in shares of ALPS Medical Breakthroughs ETF by 12.7% in the 1st quarter. Strategic Financial Services Inc. now owns 19,225 shares of the company’s stock valued at $548,000 after buying an additional 2,163 shares during the period. Rossby Financial LCC purchased a new position in ALPS Medical Breakthroughs ETF in the first quarter worth approximately $147,000. Phoenix Financial Ltd. purchased a new position in ALPS Medical Breakthroughs ETF in the first quarter worth approximately $41,785,000. Finally, Jones Financial Companies Lllp purchased a new position in ALPS Medical Breakthroughs ETF in the first quarter worth approximately $782,000.

ALPS Medical Breakthroughs ETF Trading Down 0.1%

Shares of ALPS Medical Breakthroughs ETF stock opened at $42.19 on Friday. ALPS Medical Breakthroughs ETF has a 52-week low of $22.33 and a 52-week high of $43.60. The company has a 50 day moving average of $37.12 and a 200 day moving average of $32.25.

About ALPS Medical Breakthroughs ETF

The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.